Adjuvant Chemotherapy for Stage II Right- and Left-Sided Colon Cancer: Analysis of SEER-Medicare Data

PURPOSE: Survival benefit from adjuvant chemotherapy is established for stage III colon cancer; however, uncertainty exists for stage II patients. Tumor heterogeneity, specifically microsatellite instability (MSI) which is more common in right-sided cancers, may be the reason for this observation. W...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Weiss, Jennifer M., Schumacher, Jessica, Allen, Glenn O., Neuman, Heather, Lange, Erin O’Connor, LoConte, Noelle K., Greenberg, Caprice C., Smith, Maureen A.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2014
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4016118/
https://ncbi.nlm.nih.gov/pubmed/24643898
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-014-3631-8
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge